1 - 15 of about 15
English: Abe T, Takeda Y, Takiyama T, Sasaki A, Bessho R, Sato M, Kitsunai H, Sakagami H, Abiko A, Imai K, Yuzawa S, Tanino M, Takiyama Y., A case of insulinoma diagnosed postpartum with hypoglycemic symptoms that were masked during pregnancy. , Clin Case Rep , vol.9 (p.1991 - 1998) , 2021
English: Fujita Y, Atageldiyeva KK, Takeda Y, Yanagimachi T, Makino Y, Haneda M., A Low-Carbohydrate Diet Improves Glucose Metabolism in Lean Insulinopenic Akita Mice Along With Sodium-Glucose Cotransporter 2 Inhibitor. , Front Endocrinol (Lausanne) , vol.11 (p.601594 - ) , 2020
English: Takeda Y, Fujita Y, Yanagimachi T, Maruyama N, Bessho R, Sakagami H, Honjo J, Yokoyama H, Haneda M., Establishment of Novel Specific Assay for Short-Form Glucose-Dependent Insulinotropic Polypeptide and Evaluation of Its Secretion in Nondiabetic Subjects. , Physiol Rep , vol.8 (p.e14469 - ) , 2020
English: Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Yokoyama H, Haneda M., Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes. , Front Endocrinol (Lausanne) , vol.11 (p.214 - ) , 2020
English: Bessho R, Takiyama Y, Takiyama T, Kitsunai H, Takeda Y, Sakagami H, Ota T., Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy. , Sci Rep , vol.9 (p.14754 - ) , 2019
English: Takeda Y, Fujita Y, Bessho R, Sato M, Abe T, Yanagimachi T, Sakagami H, Abiko A, Takiyama Y, Ota T, Haneda M., Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test. , BMC Endocr Disord , vol.19 (p.99 - ) , 2019
English: Takeda Y, Fujita Y, Sakai K, Abe T, Nakamura T, Yanagimachi T, Sakagami H, Honjo J, Abiko A, Makino Y, Haneda M., Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors. , Endocrinol Diabetes Metab Case Rep , 2017
English: Takeda Y, Fujita Y, Yanagimachi T, Honjo J, Abiko A, Asai M, Haneda M., Prediabetes Exhibits Decreased Disposition Index Correlated with Deterioration of Glycemic Parameters in Nonobese Japanese Subjects: A Cross-Sectional Study from Medical Examination. , Metab Syndr Relat Disord , vol.15 (p.296 - 303) , 2017
English: Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Sakagami H, Kitsunai H, Takiyama Y, Abiko A, Makino Y, Kieffer TJ, Haneda M., Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects. , Mol Metab , vol.6 (p.226 - 231) , 2016
English: Atageldiyeva K, Fujita Y, Yanagimachi T, Mizumoto K, Takeda Y, Honjo J, Takiyama Y, Abiko A, Makino Y, Haneda M., Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice. , PLoS One , vol.11 (p.e0157672 - ) , 2016
English: Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Atageldiyeva KK, Takiyama Y, Abiko A, Makino Y, Kieffer TJ, Haneda M., Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP (1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice. , Diabetologia , vol.59 (p.533 - 541) , 2016
English: Fujita Y, Yanagimachi T, Takeda Y, Honjo J, Takiyama Y, Abiko A, Makino Y, Haneda M., Alternative form of glucose-dependent insulinotropic polypepide and its physiology. , J Diabetes Investig , vol.7 (suppl 1) (p.33 - 37) , 2016
English: Kitsunai H, Makino Y, Sakagami H, Mizumoto K, Yanagimachi T, Atageldiyeva K, Takeda Y, Fujita Y, Abiko A, Takiyama Y, Haneda M., High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells. , Physiol Rep , vol.4 (p.e12730 - ) , 2016
English: Sakagami H, Makino Y, Mizumoto K, Isoe T, Takeda Y, Watanabe J, Fujita Y, Takiyama Y, Abiko A, Haneda M., Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells. , Am J Physiol Endocrinol Metab , vol.306 (p.E1065 - 1076) , 2014
English: Takeda Y, Fujita Y, Honjo J, Yanagimachi T, Sakagami H, Takiyama Y, Makino Y, Abiko A, Kieffer TJ, Haneda M., Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. , Diabetologia , vol.55 (p.404 - 412) , 2012
Page: [<<PREV] [1] [NEXT>>]
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.